Serum Institute of India to produce Russia-made COVID-19 Vaccine Sputnik-V

Serum Institute of India (SII) has entered into an agreement with Russian Direct Investment Fund (RDIF), Russia's sovereign wealth fund, for the production of Sputnik-V COVID-19 vaccine. SII and RDIF said in a joint statement on July 13 that the first batch of Sputnik V vaccine doses are expected to be produced at SII's facilities in September.